Want to join the conversation?
At December 31, 2015, $XRAY had authorization to maintain up to 34MM shares of treasury stock under its stock repurchase program as approved by the BoD. Under this program, the company purchased approx. 2.1MM shares, or approx. 1.5% of average diluted shares outstanding, during 2015 at an average price of $52.50.
$BABA seems to be on a roll! But increasing its yearly sales outlook from 48% to 54% seems over-expectation from the company's part, doesn't it?
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?
$YHOO is reporting today after market close. Nobody cares about this stock.